All Curated Mutation Sites in JEV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in JEV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
C
  
E
  
NS1
  
NS2A
  
NS2B
  
NS3
  
NS4B
  
NS5
  
prM
  

Keyword: NS3
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 32461319 R226G
NS3
NS3
JEV Infection
Cell line
View
2 32461319 R202W
NS3
NS3
JEV Infection
Cell line
View
3 31381617 I109F
NS3
NS3
Cell line
G
View
4 31381617 E122K
NS3
NS3
Cell line
G
View
5 31381617 R218K
NS3
NS3
Cell line
G
View
6 31381617 D177E
NS3
NS3
Cell line
G
View
7 31381617 P105A
NS3
NS3
Cell line
G
View
8 31381617 S14L
NS3
NS3
Cell line
G
View
9 31381617 A78S
NS3
NS3
Cell line
G
View
10 31381617 A105P
NS3
NS3
Cell line
G
View
11 31381617 E177D
NS3
NS3
Cell line
G
View
12 31381617 N182S
NS3
NS3
Cell line
G
View
13 31381617 R185K
NS3
NS3
Cell line
G
View
14 31381617 E354D
NS3
NS3
Cell line
G
View
15 31381617 K15R
NS3
NS3
Cell line
G
View
16 31381617 V123I
NS3
NS3
Cell line
G
View
17 31381617 Q188R
NS3
NS3
Cell line
G
View
18 31381617 R237K
NS3
NS3
Cell line
G
View
19 31381617 E177E
NS3
NS3
Cell line
G
View
20 39775684 A105G
NS3
NS3
Cell line
R
View
21 39775684 M59V
NS3
NS3
Cell line
R
View
22 10620709 D285A
NS3
NS3
Cell line
View
23 24709585 G5288A
NS3
NS3
Cell line
JEV Infection
R
View
24 24709585 T6259G
NS3
NS3
Cell line
JEV Infection
R
View
25 24709585 V551G
NS3
NS3
Cell line
JEV Infection
R
View
Contents
Description

The table shows all curated mutation sites of JEV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.